| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.13B | $2.02B | $2.07B |
| YoY Revenue Growth % | +5.4% | -2.1% | — |
| Gross Profit | $755.9M | $717.3M | — |
| Gross Margin % | 35.5% | 35.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $269.0M | $243.6M | $262.4M |
| Operating Margin % | 12.6% | 12.1% | 12.7% |
| Net Income (GAAP) | $147.1M | $180.3M | $193.3M |
| EBITDA (Normalized) | $305.2M | $277.0M | $336.8M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $238.9M | $261.4M | $315.7M |
| Capital Expenditures (CapEx) | $45.3M | $41.7M | $92.9M |
| Free Cash Flow (FCF) | $193.5M | $219.7M | $222.8M |
| FCF Margin % | 9.1% | 10.9% | 10.8% |
| Return on Invested Capital (ROIC %) | 12.7% | 13.1% | 13.9% |
| Cash & Short-Term Equivalents | $99.7M | $220.5M | — |
| Total Debt (Short + Long Term) | $455.0M | $426.0M | $579.9M |
| Total Stockholders' Equity | $1.32B | $1.27B | $1.19B |